Hims Hers Health is trading at $34.03 (-4.01%) as macroeconomic pressures and competitive threats weigh on the stock.
- Broader risk sentiment is being driven by escalating U.S.-Iran tensions and rising crude prices, which have pressured growth-oriented names.
- Investor concerns are mounting following Amazon’s entry into the weight management space via One Medical, signaling increased competition for the company.
- Sentiment remains fragile due to ongoing GLP-1-related headwinds and weakening price momentum following recent market volatility.